Movember: A moustache (started in England) growing charity event in November that raises funds and awareness for men's health. Source |
During the month of November men everywhere opt out of shaving and sport their best mustaches in support of men’s health. As if it were fate, scientists published discovery this month that could prevent tumors from spreading. Researchers found a way to stop the body from producing a molecule found in new blood vessels that result in new prostate cancer cells, basically stopping tumors from spreading any further.
What is a tumor and what is prostate cancer?
A tumor (or a neoplasm) is an abnormal growth of tissue.
This is a result of cells that have an abnormal growth pattern. Some tumors are
not cancer, known as benign tumors, which do not spread to other areas of the
body. Malignant tumors, on the other hand, are tumors that have the potential
to spread and invade other parts of the body. If they spread to vital organs,
cancer becomes deadly.
Tumors need a constant supply of nutrient-rich blood to
spread. Blood is supplied to tumors through a mechanism known as angiogenesis:
the process in which new blood vessels are formed from old ones.
Prostate cancer is a malignant tumor that develops in the
prostate gland. Many times the cancer cells spread from the prostate to other
parts of the body through lymph nodes. Symptoms of prostate cancer include pain
in the pelvis or back when urinating, difficulty urinating, and blood in the
urine.
How have scientists figured out a way to prevent prostate cancer from spreading?
Cancer treatment is a research priority throughout the
world, and recently researchers may have discovered a breakthrough in ways to treat
it. If the blood supply to a tumor is cut-off, the tumor will stop growing; the
same way a car will stop going if it’s gasoline supply is cut-off. Scientists
from University of Bristol and the University of Nottingham identified
molecules called SRPK1 that play a vital role in angiogenesis.
Using samples of prostate cancer in mice, the researchers found that
SRPK1 levels increase as the cancer progresses and spreads more aggressively.
They also found that if they decrease levels of SRPK1 in mice, they also
inhibited tumor growth.
Figure from study. Arrows indicate blood vessels. The figure on the right shows a reduction in tumors when SRPK1 is suppressed. |
The inhibitor for SRPK1 was developed by Biotech company
Exonate as a drug treatment for diseases that display abnormal vessel
development, like macular degeneration (which causes blindness). When the
scientists injected mice with the drug, the tumor growth was inhibited because
vasculature growth was stopped. Because this drug targets vasculature growth,
it can likely be used to treat other types of cancer that spread with similar
mechanisms.
This new discovery is incredibly promising, not only for the
treatment of prostate cancer, but many other deadly diseases. Whether or not it
is a result of fundraising from Movember,
the awareness that Movember and No Shave November have created for men’s health
is a positive. So please gentlemen, keep growing those mustaches and checking your
health!
Cheers to your brain and thanks for reading!
P.S. if you want to know about the science of beards, the
guys at ASAPScience made this awesome video:
No comments:
Post a Comment